Advanced search
Publication Cover
Core Evidence Volume 14, 2019 - Issue
Journal homepage
138
Views
17
CrossRef citations to date
0
Altmetric
Review

Enasidenib in the treatment of relapsed/refractory acute myeloid leukemia: an evidence-based review of its place in therapy

Maria Galkin1 Department of Internal Medicine, University of California Davis School of Medicine, Sacramento, CA, USA
&
Brian A Jonas2 Department of Internal Medicine, Division of Hematology and Oncology, University of California Davis School of Medicine, Sacramento, CA, USACorrespondence[email protected]
Pages 3-17 | Published online: 26 Apr 2019

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.